Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU
New agreement applies to the polymers of the Medical Care series portfolio
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
Subscribe To Our Newsletter & Stay Updated
